Abstract

We used morphological, immunohistochemical and functional assessments to determine the impact of genetically-modified peripheral nerve (PN) grafts on axonal regeneration after injury. Grafts were assembled from acellular nerve sheaths repopulated ex vivo with Schwann cells (SCs) modified to express brain-derived neurotrophic factor (BDNF), a secretable form of ciliary neurotrophic factor (CNTF), or neurotrophin-3 (NT3). Grafts were used to repair unilateral 1 cm defects in rat peroneal nerves and 10 weeks later outcomes were compared to normal nerves and various controls: autografts, acellular grafts and grafts with unmodified SCs. The number of regenerated βIII-Tubulin positive axons was similar in all grafts with the exception of CNTF, which contained the fewest immunostained axons. There were significantly lower fiber counts in acellular, untransduced SC and NT3 groups using a PanNF antibody, suggesting a paucity of large caliber axons. In addition, NT3 grafts contained the greatest number of sensory fibres, identified with either IB4 or CGRP markers. Examination of semi- and ultra-thin sections revealed heterogeneous graft morphologies, particularly in BDNF and NT3 grafts in which the fascicular organization was pronounced. Unmyelinated axons were loosely organized in numerous Remak bundles in NT3 grafts, while the BDNF graft group displayed the lowest ratio of umyelinated to myelinated axons. Gait analysis revealed that stance width was increased in rats with CNTF and NT3 grafts, and step length involving the injured left hindlimb was significantly greater in NT3 grafted rats, suggesting enhanced sensory sensitivity in these animals. In summary, the selective expression of BDNF, CNTF or NT3 by genetically modified SCs had differential effects on PN graft morphology, the number and type of regenerating axons, myelination, and locomotor function.

Highlights

  • Peripheral nerve (PN) injuries are often microsurgically repaired by coaptation of transected nerve stumps

  • Primary Schwann cells (SCs) cultures were transduced with LV-brain-derived neurotrophic factor (BDNF), LV-ciliary neurotrophic factor (CNTF) or LV-NT3 and seeded into acellular nerve sheaths to bridge a 1 cm peroneal nerve defect

  • This size gap permits an analysis of the relative impact of each neurotrophic factor on axonal regeneration and myelination, and reduces any confounding effect related to the length of the nerve defect itself [1]

Read more

Summary

Introduction

Peripheral nerve (PN) injuries are often microsurgically repaired by coaptation of transected nerve stumps. If the nerve defect is too large, due to nerve stump retraction or following pruning to remove necrotic tissue, a bridging graft is needed to restore continuity. Autologous nerve grafts are the preferred option, commonly harvested from sensory sural nerves [1,2], yet functional recovery can be suboptimal, perhaps due to neuronal loss, deterioration of distal nerve stump, or failure to recruit Schwann cells (SCs) of the appropriate phenotype [3,4,5,6]. Harvesting autografts may result in functional impairment and neuroma formation at the donor site. Use of allograft or xenograft material requires immunosuppression, and graft rejection results in axonal loss [7,8,9]. Bridges using synthetic materials have the advantage of ease of fabrication and availability, they may not be optimal for repairing large nerve defects and may induce inflammatory reactions [12]

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call